Lilly’s triple-G drug hits 22.6% weight loss, but impact on reducing cardio risk is less clear

Velocity

How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →

Coverage (2)

• Retatrutide Helped Adults With Diabetes or Heart Disease Lose Up to 20 Percent of Their Weight, Study Finds Everyday Health · 1d ago
• Another win for Lilly’s triple-g agonist in two more Phase III trials Yahoo Finance · 1d ago

Related trends